BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 30295243)

  • 41. [Intracellular cytokine expression characteristics of activated T lymphocytes in patients with acute myeloid leukemia].
    Yang HZ; Wang J; Sun ZM
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Dec; 15(6):1161-4. PubMed ID: 18088457
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Antileukemic T-cell responses can be predicted by the composition of specific regulatory T-cell subpopulations.
    Schick J; Vogt V; Zerwes M; Kroell T; Kraemer D; Köhne CH; Hausmann A; Buhmann R; Tischer J; Schmetzer H
    J Immunother; 2013 May; 36(4):223-37. PubMed ID: 23603857
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Changes of lymphocyte subsets in acute leukemia patients after HLA-mismatched nonmyeloablative hematopoietic stem cell transplantation].
    Hu KX; Guo M; Yu CL; Wang DH; Sun QY; Qiao JH; Liu GX; Liu TQ; Ai HS
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Dec; 17(6):1527-31. PubMed ID: 20030940
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Micro-inflammation characterized by disturbed Treg/Teff balance with increasing sIL-2R in patients with type 2 diabetes.
    Cai B; Zhang J; Zhang M; Li L; Feng W; An Z; Wang L
    Exp Clin Endocrinol Diabetes; 2013 Apr; 121(4):214-9. PubMed ID: 23595796
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Expression of Aurora Family Genes in Acute Leukemia and Its Clinical Significance].
    Liu ZL; Xing Y; Li T; Wang C; Liu SF; Zhao HY; Zhang RH; Ma YJ; Zhang XY; Tian WL; Liu L; Sun H; Sun L
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Apr; 25(2):334-339. PubMed ID: 28446271
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Role of Dynamic Monitoring Chromosome Karyotypes for Evaluation of Chemotherapy Efficacy in Patients with Acute Leukemia].
    Liu YC; Li W; Wang H; Chen X; Li J; Chai T
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2015 Jun; 23(3):658-62. PubMed ID: 26117012
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Interaction between the immune system and acute myeloid leukemia: A model incorporating promotion of regulatory T cell expansion by leukemic cells.
    Nishiyama Y; Saikawa Y; Nishiyama N
    Biosystems; 2018 Mar; 165():99-105. PubMed ID: 29408212
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Dynamically monitoring minimal residual disease in acute leukemia after complete remission by multiparameter flow cytometry and its relation with prognosis].
    Sun NN; Gan SL; Sun H; Zhang QT; Liu YF; Xie XS
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Apr; 21(2):339-42. PubMed ID: 23628028
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Changes and clinical significance of CD8(+) T cell subset in patients with aplastic anemia, myelodysplastic syndrome and acute myeloid leukemia].
    Zhang JY; Xu HZ; Yin DM; Feng XM; Sui XH; Cui B; Ma CY
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Feb; 21(1):203-8. PubMed ID: 23484720
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Changes of Leukemia Stem Cells in Acute Myeloid Leukemia before and after Treatment].
    Lv JT; Yang ZG; Guang YH; Lin ZS; Xiao XX; Liu D; Shi M; Wang WS
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2018 Jun; 26(3):658-664. PubMed ID: 29950200
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Detection of T lymphocyte subsets in the peripheral blood of patients with advanced lung adenocarcinoma.
    Yan X; Zhao X; Jiao SC; Hu Y; Sun SJ; Wu LL; Wu ZY
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2012 Jun; 34(3):234-8. PubMed ID: 22776655
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Clinical features and early treatment effects in intermediate risk and poor risk acute myeloid leukemia with EVI1 positive].
    Duan WB; Gong LZ; Jia JS; Zhu HH; Zhao XS; Jiang Q; Zhao T; Wang J; Qin YZ; Huang XJ; Jiang H
    Beijing Da Xue Xue Bao Yi Xue Ban; 2017 Dec; 49(6):990-995. PubMed ID: 29263470
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [The percentage of regulatory T cells in peripheral blood of chronic lymphocytic leukemia patients and the correlations with clinical prognosis].
    Xie P; Pang N; Guo X; Wang L; Zhao F; Wang X; Qu J
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2013 Dec; 29(12):1307-11. PubMed ID: 24321076
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Change of CD4(+) CD25(+) regulatory T cells and NK Cells in peripheral blood of children with acute leukemia and its possible significance in tumor immunity].
    Wu ZL; Hu GY; Chen FX; Lu HM; Wu ZL; Li HM; Wei FG; Guan JM; Wu LP
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Jun; 18(3):709-13. PubMed ID: 20561434
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Expression of histone demethylase lysine specific demethylase 1 in acute leukemia and its clinical significance].
    Lin XM; Zhong WT; Wang CL; Wang SQ
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Dec; 19(6):1348-52. PubMed ID: 22169281
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The success of assisted reproduction technologies in relation to composition of the total regulatory T cell (Treg) pool and different Treg subsets.
    Schlossberger V; Schober L; Rehnitz J; Schaier M; Zeier M; Meuer S; Schmitt E; Toth B; Strowitzki T; Steinborn A
    Hum Reprod; 2013 Nov; 28(11):3062-73. PubMed ID: 23925397
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Diminished levels of regulatory T cell subsets (CD8+Foxp3, CD4+Foxp3 and CD4+CD39+Foxp3) but increased Foxp3 expression in adipose tissue from overweight subjects.
    Núñez Ruiz A; Cortés-Garcia JD; Cortez-Espinosa N; Herrera-Rojas PI; Ruíz-Rodríguez VM; Salgado-Bustamante M; García-Hernández MH; Reynaga-Hernández E; Martínez-Jimenez Vdel C; Portales-Pérez DP
    Nutrition; 2016 Sep; 32(9):943-54. PubMed ID: 27160497
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Identity and Diversity of Human Peripheral Th and T Regulatory Cells Defined by Single-Cell Mass Cytometry.
    Kunicki MA; Amaya Hernandez LC; Davis KL; Bacchetta R; Roncarolo MG
    J Immunol; 2018 Jan; 200(1):336-346. PubMed ID: 29180490
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Perioperative changes of cellular immune response of patients with esophageal carcinoma evaluated through detecting AgNOR content in peripheral blood T lymphocytes and T cell subsets].
    Wang JY; Dai SQ; Ye WF; Long H; Lin P; Li BJ; Rong TH
    Ai Zheng; 2005 Jul; 24(7):861-4. PubMed ID: 16004816
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Effect and Clinical Significance of Bortezomib and Thalidomide on the Memory T Cells Subsets and Regulatory T Cells in Peripheral Blood of Patients with Multiple Myeloma].
    Shi LL; Li HQ; Mei JG; Zhou XG; Li F; Song P; Zhai YP
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2018 Apr; 26(2):477-483. PubMed ID: 29665919
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.